血栓弹力图不能检测急性创伤患者的伤前抗凝状态
该回顾性病历回顾纳入2011年2月至2014年9月在一家城市一级创伤中心收治、24小时内接受血栓弹力图(TEG)的全部创伤患者54例,比较伤前使用抗凝药(华法林、达比加群或抗Xa抑制剂阿哌沙班/利伐沙班)组(27例)与未使用抗凝药组(27例)。TEG判定凝血病比例两组无差异(无抗凝组11% vs 抗凝组15%,p=0.99);而传统凝血试验(INR、aPTT)在抗凝患者中识别凝血病的比例明显更高(无抗凝组22% vs 抗凝组85%,p<0.01)。作者结论认为TEG评估伤前抗凝的临床效用有限,药物性凝血病的传统标志物应指导逆转决策。
要点
- 伤前使用华法林、达比加群或抗Xa抑制剂(阿哌沙班/利伐沙班)的创伤患者,TEG判定凝血病比例与未抗凝者无差异(无抗凝组11% vs 抗凝组15%,p=0.99)。
- 传统凝血试验(INR、aPTT)在抗凝患者中识别凝血病的比例明显高于未抗凝组(无抗凝组22% vs 抗凝组85%,p<0.01)。
- 作者结论:TEG评估伤前抗凝的临床效用有限,药物性凝血病应依据传统标志物指导逆转决策。
- 该研究为单中心回顾性病历回顾,共纳入54例患者,抗凝组27例(华法林13例、达比加群6例、抗Xa抑制剂8例),无抗凝组27例。
适用人群与场景
- 2011年2月至2014年9月在一家城市一级创伤中心收治、并在伤后24小时内接受TEG的全部创伤患者。
- 抗凝组定义为入院前用药记录中包含华法林、达比加群或抗Xa抑制剂(阿哌沙班或利伐沙班)者,其余为无抗凝组。
诊断标准与关键阈值
- TEG或传统凝血试验判定凝血病,定义为超过当地实验室参考标准。
研究设计与关键结果
- 研究类型为回顾性病历回顾,共纳入54例患者(抗凝组27例 vs 无抗凝组27例),单中心。
- 抗凝组构成为华法林13例、达比加群6例、抗Xa抑制剂8例。
- 两组基线特征相似:年龄72±13岁 vs 72±15岁(p=0.85),男性70% vs 74%(p=0.76),钝性损伤机制100% vs 100%(p=1)。
- TEG判定凝血病比例两组无差异:无抗凝组11% vs 抗凝组15%(p=0.99)。
- 传统凝血试验(INR、aPTT)判定凝血病比例:无抗凝组22% vs 抗凝组85%(p<0.01)。
证据类型、等级与局限
- 证据类型:单中心回顾性病历回顾。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者结论认为TEG评估伤前抗凝的临床效用有限,药物性凝血病的传统标志物应指导逆转决策。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Thromboelastography (TEG) has been recommended to characterize post-traumatic coagulopathy, yet no study has evaluated the impact of pre-injury anticoagulation (AC) on TEG variables. We hypothesized patients on pre-injury AC have a greater incidence of coagulopathy on TEG compared to those without AC.
METHODS: This retrospective chart review evaluated all trauma patients admitted to an urban, level one trauma center from February 2011 to September 2014 who received a TEG within the first 24h. Patients were classified as receiving pre-injury AC or no AC if their documented medications prior to admission included warfarin, dabigatran, or anti-Xa (aXa) inhibitors (apixaban or rivaroxaban). The presence of coagulopathy on TEG or conventional assays was defined by exceeding local laboratory reference standards.
RESULTS: A total of 54 patients were included (AC, n=27 [warfarin n=13, dabigatran n=6, aXa inhibitor n=8] vs. no AC, n=27). Baseline characteristics were similar between groups, including age (72±13years vs. 72±15; p=0.85), male gender (70% vs. 74%; p=0.76) and blunt mechanism of injury (100% vs. 100%; p=1). There was no difference in the number of patients determined to have coagulopathy on TEG (no AC 11% vs. AC 15%; p=0.99). Conventional tests, including the international normalized ratio (INR) and activated partial thromboplastin time (aPTT), identified coagulopathy in a high proportion of anti-coagulated patients (no AC 22% vs. AC 85%; p<0.01).
CONCLUSION: TEG has limited clinical utility to evaluate the presence of pre-injury AC. Traditional markers of drug induced coagulopathy should guide reversal decisions.
参考来源
- Ali JT, Daley MJ, Vadiei N, et al. Thromboelastogram does not detect pre-injury anticoagulation in acute trauma patients. Am J Emerg Med. 2016. PMID: 28062209. doi:10.1016/j.ajem.2016.12.061
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。